{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "33617569", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "07"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "26"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "02", "Day": "22"}], "ELocationID": ["e0247504", "10.1371/journal.pone.0247504"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "16", "Issue": "2", "PubDate": {"Year": "2021"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Genetic variation in surfactant protein-A2 alters responses to ozone.", "Pagination": {"StartPage": "e0247504", "MedlinePgn": "e0247504"}, "Abstract": {"AbstractText": ["Increased exposure to Ozone (O3) is associated with adverse health effects in individuals afflicted with respiratory diseases. Surfactant protein-A (SP-A), encoded by SP-A1 and SP-A2, is the largest protein component in pulmonary surfactant and is functionally impaired by O3-oxidation.", "We used humanized SP-A2 transgenic mice with allelic variation corresponding to a glutamine (Q) to lysine (K) amino acid substitution at position 223 in the lectin domain to determine the impact of this genetic variation in regards to O3 exposure.", "Mice were exposed to 2ppm O3 or Filtered Air (FA) for 3 hours and 24 hrs post-challenge pulmonary function tests and other parameters associated with inflammation were assessed in the bronchoalveolar lavage (BAL) fluid and lung tissue. Additionally, mouse tracheal epithelial cells were cultured and TEER measurements recorded for each genotype to determine baseline epithelial integrity.", "Compared to FA, O3 exposure led to significantly increased sensitivity to methacholine challenge in all groups of mice. SP-A2 223Q variant mice were significantly protected from O3-induced AHR compared to SP-A-/- and SP-A2 223K mice. Neutrophilia was observed in all genotypes of mice post O3-exposure, however, SP-A2 223Q mice had a significantly lower percentage of neutrophils compared to SP-A-/- mice. Albumin levels in BAL were unchanged in O3-exposed SP-A2 223Q mice compared to their FA controls, while levels were significantly increased in all other genotypes of O3-exposed mice. SP-A 223Q MTECS has significant higher TEER values than all other genotypes, and WT MTECS has significantly higher TEER than the SP-A KO and SP-A 223K MTECS.", "Taken together, our study suggests that expression of a glutamine (Q) as position 223 in SP-A2, as opposed to expression of lysine (K), is more protective in acute exposures to ozone and results in attenuated O3-induced AHR, neutrophilia, and vascular permeability."]}, "AuthorList": [{"Identifier": ["0000-0001-9253-1279"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, University of Arizona, Tucson, Arizona, United States of America."}], "LastName": "Pederson", "ForeName": "William P", "Initials": "WP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Duke University, Durham, North Carolina, United States of America."}], "LastName": "Cyphert-Daly", "ForeName": "Jaime M", "Initials": "JM"}, {"Identifier": ["0000-0002-3465-9861"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Duke University, Durham, North Carolina, United States of America."}], "LastName": "Tighe", "ForeName": "Robert M", "Initials": "RM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, Duke University, Durham, North Carolina, United States of America."}], "LastName": "Que", "ForeName": "Loretta G", "Initials": "LG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Asthma and Airways Disease Research Center, Tucson, Arizona, United States of America."}, {"Identifier": [], "Affiliation": "Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona, United States of America."}], "LastName": "Ledford", "ForeName": "Julie G", "Initials": "JG"}], "GrantList": [{"GrantID": "P30 ES006694", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 ES027574", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 HL125602", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R21 AI135935", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Pulmonary Surfactant-Associated Protein A"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Airway Resistance"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Capillary Permeability"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": [], "DescriptorName": "Genetic Variation"}, {"QualifierName": ["genetics"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["genetics"], "DescriptorName": "Pulmonary Surfactant-Associated Protein A"}, {"QualifierName": [], "DescriptorName": "Mice"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Brunekreef B. The continuing challenge of air pollution. Eur Respir J. 2010;36(4):704\u20135. 10.1183/09031936.00081910", "ArticleIdList": ["10.1183/09031936.00081910", "20889454"]}, {"Citation": "Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005;5(1):58\u201368. 10.1038/nri1528", "ArticleIdList": ["10.1038/nri1528", "15630429"]}, {"Citation": "Dy ABC, Tanyaratsrisakul S, Voelker DR, Ledford JG. The Emerging Roles of Surfactant Protein-A in Asthma. J Clin Cell Immunol. 2018;9(4). 10.4172/2155-9899.1000553", "ArticleIdList": ["10.4172/2155-9899.1000553", "PMC6092951", "30123671"]}, {"Citation": "Wang G, Bates-Kenney SR, Tao JQ, Phelps DS, Floros J. Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry. 2004;43(14):4227\u201339. 10.1021/bi036023i", "ArticleIdList": ["10.1021/bi036023i", "15065867"]}, {"Citation": "Ledford JG, Addison KJ, Francisco D, Foster MW, Voelker DR, Que LG, et al. Genetic Variation in Surfactant Protein-A2 Results in Altered Regulation of Eosinophil Activities and Enhanced Eosinophilia in Patients with Asthma. Ann Am Thorac Soc. 2016;13 Suppl 1:S101 10.1513/AnnalsATS.201508-520MG", "ArticleIdList": ["10.1513/AnnalsATS.201508-520MG", "PMC5015737", "27027938"]}, {"Citation": "Center N, 565 for Biotechnology Information NLoM, Bethesda, MD: Database of Single Nucleotide Polymorphisms (dbSNP) Accessed January 2019"}, {"Citation": "Ledford JG, Voelker DR, Addison KJ, Wang Y, Nikam VS, Degan S, et al. Genetic variation in SP-A2 leads to differential binding to Mycoplasma pneumoniae membranes and regulation of host responses. J Immunol. 2015;194(12):6123\u201332. 10.4049/jimmunol.1500104", "ArticleIdList": ["10.4049/jimmunol.1500104", "PMC4458406", "25957169"]}, {"Citation": "Birukova A, Cyphert-Daly J, Cumming RI, Yu YR, Gowdy KM, Que LG, et al. Sex Modifies Acute Ozone-Mediated Airway Physiologic Responses. Toxicol Sci. 2019;169(2):499\u2013510. 10.1093/toxsci/kfz056", "ArticleIdList": ["10.1093/toxsci/kfz056", "PMC6542336", "30825310"]}, {"Citation": "Tighe RM, Li Z, Potts EN, Frush S, Liu N, Gunn MD, et al. Ozone inhalation promotes CX3CR1-dependent maturation of resident lung macrophages that limit oxidative stress and inflammation. J Immunol. 2011;187(9):4800\u20138. 10.4049/jimmunol.1101312", "ArticleIdList": ["10.4049/jimmunol.1101312", "PMC3197861", "21930959"]}, {"Citation": "Wiester MJ, Tepper JS, King ME, Menache MG, Costa DL. Comparative study of ozone (O3) uptake in three strains of rats and in the guinea pig. Toxicol Appl Pharmacol. 1988;96(1):140\u20136. 10.1016/0041-008x(88)90256-6", "ArticleIdList": ["10.1016/0041-008x(88)90256-6", "3188019"]}, {"Citation": "Eight-Hour Average Ozone Concentrations2015. www3.epa.gov/region1/airquality/avg8hr.html."}, {"Citation": "Hatch GE, Slade R, Harris LP, McDonnell WF, Devlin RB, Koren HS, et al. Ozone dose and effect in humans and rats. A comparison using oxygen-18 labeling and bronchoalveolar lavage. Am J Respir Crit Care Med. 1994;150(3):676\u201383. 10.1164/ajrccm.150.3.8087337", "ArticleIdList": ["10.1164/ajrccm.150.3.8087337", "8087337"]}, {"Citation": "Addison KJ, Morse J, Robichaud A, Daines MO, Ledford JG. A Novel in vivo System to Test Bronchodilators. J Infect Pulm Dis. 2017;3(1). 10.16966/2470-3176.120", "ArticleIdList": ["10.16966/2470-3176.120", "PMC5375107", "28367537"]}, {"Citation": "Shalaby KH, Gold LG, Schuessler TF, Martin JG, Robichaud A. Combined forced oscillation and forced expiration measurements in mice for the assessment of airway hyperresponsiveness. Respir Res. 2010;11:82 10.1186/1465-9921-11-82", "ArticleIdList": ["10.1186/1465-9921-11-82", "PMC2904286", "20565957"]}, {"Citation": "Michaudel C, Fauconnier L, Jule Y, Ryffel B. Functional and morphological differences of the lung upon acute and chronic ozone exposure in mice. Sci Rep. 2018;8(1):10611 10.1038/s41598-018-28261-9", "ArticleIdList": ["10.1038/s41598-018-28261-9", "PMC6045627", "30006538"]}, {"Citation": "Casals C, Campanero-Rhodes MA, Garcia-Fojeda B, Solis D. The Role of Collectins and Galectins in Lung Innate Immune Defense. Front Immunol. 2018;9:1998 10.3389/fimmu.2018.01998", "ArticleIdList": ["10.3389/fimmu.2018.01998", "PMC6131309", "30233589"]}, {"Citation": "Bai Y, Galetskiy D, Damoc E, Paschen C, Liu Z, Griese M, et al. High resolution mass spectrometric alveolar proteomics: identification of surfactant protein SP-A and SP-D modifications in proteinosis and cystic fibrosis patients. Proteomics. 2004;4(8):2300\u20139. 10.1002/pmic.200400855", "ArticleIdList": ["10.1002/pmic.200400855", "15274124"]}, {"Citation": "Korfhagen TR. Surfactant protein A (SP-A)-mediated bacterial clearance: SP-A and cystic fibrosis. Am J Respir Cell Mol Biol. 2001;25(6):668\u201372. 10.1165/ajrcmb.25.6.f221", "ArticleIdList": ["10.1165/ajrcmb.25.6.f221", "11726390"]}, {"Citation": "Ren J, Deng Y, Xiao B, Wang G, Tao Z. Protective effects of exogenous surfactant protein A in allergic rhinitis: a mouse model. Ann Otol Rhinol Laryngol. 2013;122(4):240\u20136. 10.1177/000348941312200405", "ArticleIdList": ["10.1177/000348941312200405", "23697321"]}, {"Citation": "Chang EH. The role of surfactant protein-A in sinusitis. Curr Opin Allergy Clin Immunol. 2019;19(1):26\u20139. 10.1097/ACI.0000000000000500", "ArticleIdList": ["10.1097/ACI.0000000000000500", "30507715"]}, {"Citation": "Mitsuhashi A, Goto H, Kuramoto T, Tabata S, Yukishige S, Abe S, et al. Surfactant protein A suppresses lung cancer progression by regulating the polarization of tumor-associated macrophages. Am J Pathol. 2013;182(5):1843\u201353. 10.1016/j.ajpath.2013.01.030", "ArticleIdList": ["10.1016/j.ajpath.2013.01.030", "PMC4429178", "23499372"]}, {"Citation": "Goto H, Ledford JG, Mukherjee S, Noble PW, Williams KL, Wright JR. The role of surfactant protein A in bleomycin-induced acute lung injury. Am J Respir Crit Care Med. 2010;181(12):1336\u201344. 10.1164/rccm.200907-1002OC", "ArticleIdList": ["10.1164/rccm.200907-1002OC", "PMC2894409", "20167853"]}, {"Citation": "Lugogo N, Francisco D, Addison KJ, Manne A, Pederson W, Ingram JL, et al. Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications. J Allergy Clin Immunol. 2018;141(3):918\u201326 e3. 10.1016/j.jaci.2017.05.028", "ArticleIdList": ["10.1016/j.jaci.2017.05.028", "PMC5732097", "28624607"]}, {"Citation": "Wang Y, Voelker DR, Lugogo NL, Wang G, Floros J, Ingram JL, et al. Surfactant protein A is defective in abrogating inflammation in asthma. Am J Physiol Lung Cell Mol Physiol. 2011;301(4):L598\u2013606. 10.1152/ajplung.00381.2010", "ArticleIdList": ["10.1152/ajplung.00381.2010", "PMC3191759", "21784968"]}, {"Citation": "Larstad M, Almstrand AC, Larsson P, Bake B, Larsson S, Ljungstrom E, et al. Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study. PLoS One. 2015;10(12):e0144463 10.1371/journal.pone.0144463", "ArticleIdList": ["10.1371/journal.pone.0144463", "PMC4676630", "26656890"]}, {"Citation": "Vlachaki EM, Koutsopoulos AV, Tzanakis N, Neofytou E, Siganaki M, Drositis I, et al. Altered surfactant protein-A expression in type II pneumocytes in COPD. Chest. 2010;137(1):37\u201345. 10.1378/chest.09-1029", "ArticleIdList": ["10.1378/chest.09-1029", "19741063"]}, {"Citation": "dbSNP Short genetic variations [https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=rs1965708]."}, {"Citation": "Asthma and African Americans. U.S. Department of Health and Human Services Office of Minority Health [Website]. [http://minorityhealth.hhs.gov/omh/browse.aspx?lvl=4&lvlid=15]."}, {"Citation": "Dy ABC, Arif MZ, Addison KJ, Que LG, Boitano S, Kraft M, et al. Genetic Variation in Surfactant Protein-A2 Delays Resolution of Eosinophilia in Asthma. J Immunol. 2019;203(5):1122\u201330. 10.4049/jimmunol.1900546", "ArticleIdList": ["10.4049/jimmunol.1900546", "PMC6702058", "31350355"]}, {"Citation": "Pettigrew MM, Gent JF, Zhu Y, Triche EW, Belanger KD, Holford TR, et al. Respiratory symptoms among infants at risk for asthma: association with surfactant protein A haplotypes. BMC Med Genet. 2007;8:15 10.1186/1471-2350-8-15", "ArticleIdList": ["10.1186/1471-2350-8-15", "PMC1852548", "17407567"]}, {"Citation": "Haataja R, Ramet M, Marttila R, Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet. 2000;9(18):2751\u201360. 10.1093/hmg/9.18.2751", "ArticleIdList": ["10.1093/hmg/9.18.2751", "11063734"]}, {"Citation": "Marttila R, Haataja R, Guttentag S, Hallman M. Surfactant protein A and B genetic variants in respiratory distress syndrome in singletons and twins. Am J Respir Crit Care Med. 2003;168(10):1216\u201322. 10.1164/rccm.200304-524OC", "ArticleIdList": ["10.1164/rccm.200304-524OC", "12947025"]}, {"Citation": "Marttila R, Haataja R, Ramet M, Pokela ML, Tammela O, Hallman M. Surfactant protein A gene locus and respiratory distress syndrome in Finnish premature twin pairs. Ann Med. 2003;35(5):344\u201352. 10.1080/07853890310006389", "ArticleIdList": ["10.1080/07853890310006389", "12952021"]}, {"Citation": "Lofgren J, Ramet M, Renko M, Marttila R, Hallman M. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis. 2002;185(3):283\u20139. 10.1086/338473", "ArticleIdList": ["10.1086/338473", "11807709"]}, {"Citation": "Ramet M, Lofgren J, Alho OP, Hallman M. Surfactant protein-A gene locus associated with recurrent otitis media. J Pediatr. 2001;138(2):266\u20138. 10.1067/mpd.2001.110133", "ArticleIdList": ["10.1067/mpd.2001.110133", "11174628"]}, {"Citation": "Pettigrew MM, Gent JF, Zhu Y, Triche EW, Belanger KD, Holford TR, et al. Association of surfactant protein A polymorphisms with otitis media in infants at risk for asthma. BMC Med Genet. 2006;7:68 10.1186/1471-2350-7-68", "ArticleIdList": ["10.1186/1471-2350-7-68", "PMC1557482", "16884531"]}, {"Citation": "Haque R, Umstead TM, Ponnuru P, Guo X, Hawgood S, Phelps DS, et al. Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice. Toxicol Appl Pharmacol. 2007;220(1):72\u201382. 10.1016/j.taap.2006.12.017", "ArticleIdList": ["10.1016/j.taap.2006.12.017", "PMC1906716", "17307210"]}, {"Citation": "Francis M, Groves AM, Sun R, Cervelli JA, Choi H, Laskin JD, et al. Editor\u2019s Highlight: CCR2 Regulates Inflammatory Cell Accumulation in the Lung and Tissue Injury following Ozone Exposure. Toxicol Sci. 2017;155(2):474\u201384. 10.1093/toxsci/kfw226", "ArticleIdList": ["10.1093/toxsci/kfw226", "PMC5291213", "27837169"]}, {"Citation": "Connor AJ, Laskin JD, Laskin DL. Ozone-induced lung injury and sterile inflammation. Role of toll-like receptor 4. Exp Mol Pathol. 2012;92(2):229\u201335. 10.1016/j.yexmp.2012.01.004", "ArticleIdList": ["10.1016/j.yexmp.2012.01.004", "PMC3507381", "22300504"]}, {"Citation": "Que LG, Stiles JV, Sundy JS, Foster WM. Pulmonary function, bronchial reactivity, and epithelial permeability are response phenotypes to ozone and develop differentially in healthy humans. J Appl Physiol (1985). 2011;111(3):679\u201387.", "ArticleIdList": ["PMC3174797", "21700892"]}, {"Citation": "Sokolowska M, Quesniaux VFJ, Akdis CA, Chung KF, Ryffel B, Togbe D. Acute Respiratory Barrier Disruption by Ozone Exposure in Mice. Front Immunol. 2019;10:2169 10.3389/fimmu.2019.02169", "ArticleIdList": ["10.3389/fimmu.2019.02169", "PMC6758598", "31608051"]}, {"Citation": "Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. TEER measurement techniques for in vitro barrier model systems. J Lab Autom. 2015;20(2):107\u201326. 10.1177/2211068214561025", "ArticleIdList": ["10.1177/2211068214561025", "PMC4652793", "25586998"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "10", "Day": "14"}, {"Year": "2021", "Month": "2", "Day": "8"}, {"Year": "2021", "Month": "2", "Day": "22", "Hour": "17", "Minute": "11"}, {"Year": "2021", "Month": "2", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["33617569", "PMC7899376", "10.1371/journal.pone.0247504", "PONE-D-20-32359"]}}], "PubmedBookArticle": []}